AtriCure (ATRC)
(Delayed Data from NSDQ)
$21.43 USD
-0.62 (-2.81%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $21.44 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Balance Sheet
Fiscal Year End for AtriCure, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 137 | 121 | 119 | 244 | 82 |
Receivables | 53 | 43 | 33 | 23 | 28 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 68 | 46 | 39 | 35 | 29 |
Other Current Assets | 9 | 5 | 5 | 4 | 4 |
Total Current Assets | 266 | 215 | 196 | 307 | 143 |
Net Property & Equipment | 42 | 39 | 31 | 28 | 33 |
Investments & Advances | 0 | 52 | 104 | 14 | 13 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 299 | 274 | 278 | 363 | 365 |
Deposits & Other Assets | 2 | 2 | 1 | 0 | 1 |
Total Assets | 614 | 585 | 615 | 715 | 558 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 27 | 20 | 19 | 13 | 15 |
Current Portion Long-Term Debt | 3 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 45 | 33 | 36 | 28 | 33 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 5 | 2 | 8 | 2 |
Total Current Liabilities | 75 | 58 | 56 | 49 | 50 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 61 | 66 | 60 | 53 | 60 |
Non-Current Capital Leases | 8 | 0 | 10 | 11 | 12 |
Other Non-Current Liabilities | 1 | 1 | 1 | 187 | 186 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 148 | 129 | 132 | 302 | 311 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 824 | 787 | 765 | 742 | 530 |
Retained Earnings | -357 | -327 | -280 | -330 | -282 |
Other Equity | -1 | -4 | -1 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 466 | 457 | 484 | 412 | 247 |
Total Liabilities & Shareholder's Equity | 614 | 585 | 615 | 715 | 558 |
Total Common Equity | 466 | 457 | 484 | 412 | 247 |
Shares Outstanding | 47.40 | 46.50 | 45.90 | 45.00 | 39.50 |
Book Value Per Share | 9.83 | 9.82 | 10.54 | 9.16 | 6.26 |
Fiscal Year End for AtriCure, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 114 | 106 | 137 | 133 | 127 |
Receivables | 56 | 55 | 53 | 52 | 48 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 74 | 72 | 68 | 62 | 55 |
Other Current Assets | 10 | 12 | 9 | 6 | 7 |
Total Current Assets | 253 | 245 | 266 | 253 | 238 |
Net Property & Equipment | 42 | 42 | 42 | 41 | 41 |
Investments & Advances | 0 | 0 | 0 | 0 | 8 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 295 | 297 | 299 | 300 | 302 |
Deposits & Other Assets | 3 | 3 | 2 | 2 | 2 |
Total Assets | 597 | 592 | 614 | 600 | 594 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 27 | 29 | 27 | 25 | 24 |
Current Portion Long-Term Debt | 0 | 0 | 3 | 21 | 16 |
Current Portion Capital Leases | 3 | 3 | 0 | 0 | 0 |
Accrued Expenses | 32 | 30 | 45 | 37 | 32 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 61 | 61 | 75 | 83 | 71 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 62 | 62 | 61 | 50 | 47 |
Non-Current Capital Leases | 11 | 11 | 8 | 8 | 9 |
Other Non-Current Liabilities | 1 | 1 | 1 | 1 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 135 | 135 | 148 | 137 | 132 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 841 | 827 | 824 | 812 | 803 |
Retained Earnings | -378 | -370 | -357 | -347 | -338 |
Other Equity | -1 | -1 | -1 | -2 | -3 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 462 | 456 | 466 | 463 | 462 |
Total Liabilities & Shareholder's Equity | 597 | 592 | 614 | 600 | 594 |
Total Common Equity | 462 | 456 | 466 | 463 | 462 |
Shares Outstanding | 48.70 | 48.30 | 47.40 | 47.40 | 47.30 |
Book Value Per Share | 9.49 | 9.45 | 9.83 | 9.76 | 9.78 |